Speaker Profile
Ph.D., VP of Research, Complete Genomics
Biography
Dr. Yuan Jiang is the Vice President of Research with over a decade of experience in genomic technology development and commercialization. An expert in genomics, molecular biology, and NGS, Dr. Jiang has successfully led cross-functional teams in the creation of cutting-edge products, from concept through to market. She has been instrumental in launching key NGS and molecular diagnostic tools, including spatial genomics, NGS applications and CRISPR-Cas technologies. With a Ph.D. in Genetics from Cornell University, Dr. Jiang is a proven innovator and leader, holding several patents in advanced genomic methodologies. Her work continues to drive advancements in genomic science and its practical applications.
Talk
Mapping the Future: How Stereo-seq Accelerates Multi-Omics Discovery
Stereo-seq is a groundbreaking spatial transcriptomics technology enabling high-resolution, species agnostic, whole transcriptomics mapping across tissue sections. By integrating multiomics, it provides unparalleled insights into cellular heterogeneity, spatial organization, and molecular interactions within tissues. This approach advances our understanding of complex biological processes, such as cancer progression and immune response, facilitating precision medicine.
Spatial Showcase:
Complete Genomics
Complete Genomics is a pioneering life sciences company, founded in 2005, offering a comprehensive portfolio including sample extraction, library preparation, lab automation, and sequencing platforms. Our mission is to drive genomics forward with complete sequencing solutions that improve lives.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
